We are a French CRO compagny. Since 2009, we are offering you services in the first stage of R&D and regular studies (GLP) specializing in the evaluation :
of regular toxicity
of predictive toxicology
on the efficiency of ingredients and products (in particular face skin microbiome and endocrine disruptors)
Atoxigen has the JEI status (innovative enterprise) and is supported by: BPI France, Conseil régional d’aquitaine, EADS développement and FRED.